Molecular therapeutics. Methotrexate and its mechanism of action

This publication has 93 references indexed in Scilit:

• Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation
  Arthritis & Rheumatism, 1996
• METHOTREXATE ACTION IN RHEUMATOID ARTHRITIS: STIMULATION OF CYTOKINE INHIBITOR AND INHIBITION OF CHEMOKINE PRODUCTION BY PERIPHERAL BLOOD MONONUCLEAR CELLS
  Rheumatology, 1995
• Low‐dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. results of a multicenter randomized, double‐blind, placebo‐controlled trial
  Arthritis & Rheumatism, 1993
• IgM-rheumatoid factor and responses to second-line drugs in rheumatoid arthritis
  Inflammation Research, 1991
• Inhibition of neutrophil adherence to endothelial cells by 3-deazaadenosine
  Inflammation Research, 1989
• Alteration of interleukin-1 production and the acute phase response following medication of adjuvant arthritic rats with cyclosporin-A or methotrexate
  International Journal of Immunopharmacology, 1988
• Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis
  New England Journal of Medicine, 1985
• Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus
  Clinical Immunology and Immunopathology, 1984
• The action of the adenosylhomocysteine hydrolase inhibitor, 3-deazaadenosine, on phagocytic function of mouse macrophages and human monocytes
  Biochemical and Biophysical Research Communications, 1978
• Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cells
  Cell, 1977